Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Dietary Fiber in CKD: A Systematic Review and Meta-analysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01844882
Recruitment Status : Completed
First Posted : May 3, 2013
Last Update Posted : November 21, 2014
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

Brief Summary:
Chronic kidney disease (CKD) is a debilitating condition in which there is a gradual decline of renal function associated with increased overall mortality. Most dietary guidelines for CKD focus on limiting protein intake (nitrogen) and high phosphorus-containing foods. However, increasing dietary fiber has been proposed to increase fecal nitrogen excretion which may ameliorate the progress of CKD. We therefore plan to conduct a systematic review and meta-analysis on clinical trials to assess the effect of fiber on urea and creatinine as classical markers of a state of uremia in individuals with CKD. We hypothesize that increasing fiber intakes will improve urea and creatinine levels in individuals with CKD.

Condition or disease
Chronic Kidney Disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 1 participants
Time Perspective: Retrospective
Official Title: The Effects of Dietary Fiber on Uremic Retention Solutes in CKD: A Systematic Review and Meta-analysis
Study Start Date : January 2012
Actual Primary Completion Date : August 2013
Actual Study Completion Date : August 2013

Resource links provided by the National Library of Medicine


Group/Cohort
Chronic Kidney Disease



Primary Outcome Measures :
  1. Creatinine [ Time Frame: 1.5 years ]
  2. urea [ Time Frame: 1.5 years ]

Secondary Outcome Measures :
  1. Phosphorus [ Time Frame: 1.5 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients with Chronic Kidney Disease (CKD)
Criteria

Inclusion Criteria:

  • Dietary trials in humans
  • Randomized treatment allocation
  • Suitable control (low fiber)
  • viable endpoint data

Exclusion Criteria:

  • Non-human studies
  • Nonrandomized treatment allocation
  • Lack of a suitable control (high protein)
  • no viable endpoint data
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01844882    
Other Study ID Numbers: SMH-CKD-2013
First Posted: May 3, 2013    Key Record Dates
Last Update Posted: November 21, 2014
Last Verified: November 2014
Keywords provided by St. Michael's Hospital, Toronto:
The effects
dietary
fiber
kidney function
CKD patients
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency